<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9731208" created="30/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9731208</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">An <term id="T1" lex="allosteric_drug" sem="Organic_compound_other">allosteric drug</term>, <term id="T2" lex="o,o&apos;-bismyristoyl_thiamine_disulfide" sem="Organic_compound_other">o,o&apos;-bismyristoyl thiamine disulfide</term>, suppresses <term id="T3" lex="HIV-1_replication" sem="Other"><term id="T4" lex="HIV-1" sem="Virus">HIV-1</term> replication</term> through prevention of <term id="T5" lex="nuclear_translocation" sem="Other">nuclear translocation</term> of both <term id="T6" lex="HIV-1_Tat" sem="Protein_molecule"><term id="T7" lex="HIV-1" sem="Virus">HIV-1</term> <term id="A1" sem="Protein_molecule">Tat</term></term> and <term id="T8" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>.</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="E4"/>
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, <clueType>suppresses</clueType> HIV-1 replication <linkCause>through</linkCause> prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="E5"/>
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, <clueType>suppresses</clueType> HIV-1 replication <linkCause>through</linkCause> prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event KT="Other" id="E3">
<type class="Viral_life_cycle"/>
<theme idref="T4"/>
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 <clueType>replication</clueType> through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E4">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T2"/>
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through <clueType>prevention</clueType> <linkTheme>of</linkTheme> nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E5">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T2"/>
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through <clueType>prevention</clueType> <linkTheme>of</linkTheme> nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event KT="Other" id="E6">
<type class="Localization"/>
<theme idref="T7" idref1="A1"/>
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event KT="Other" id="E7">
<type class="Localization"/>
<theme idref="T7" idref1="T8"/>
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> both HIV-1 Tat and NF-kappa B.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The efficacy of <term id="T9" lex="o,o&apos;-bismyristoyl_thiamine_disulfide" sem="Organic_compound_other">o,o&apos;-bismyristoyl thiamine disulfide</term> (<term id="T10" lex="BMT" sem="Organic_compound_other">BMT</term>) was examined in detail against <term id="T11" lex="HIV-1_laboratory_isolates" sem="Virus"><term id="T12" lex="HIV-1" sem="Virus">HIV-1</term> laboratory isolates</term> (<term id="T13" lex="HTLV-IIIB" sem="Virus">HTLV-IIIB</term>, <term id="T14" lex="JRFL" sem="Virus">JRFL</term>, and <term id="T15" lex="MN" sem="Virus">MN</term>), <term id="T16" lex="primary_isolate" sem="Virus">primary isolates</term> (<term id="T17" lex="KMT" sem="Virus">KMT</term> and <term id="T18" lex="KMO" sem="Virus">KMO</term>), and <term id="T19" lex="simian_immunodeficiency_virus" sem="Virus">simian immunodeficiency virus</term> (<term id="T20" lex="SIVmac251" sem="Virus">SIVmac251</term>) in vitro.</sentence>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T13"/>
<cause idref="T10"/>
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was <clueKT>examined</clueKT> in detail <linkTheme>against</linkTheme> <corefTheme>HIV-1 laboratory isolates</corefTheme> (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T14"/>
<cause idref="T10"/>
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was <clueKT>examined</clueKT> in detail <linkTheme>against</linkTheme> <corefTheme>HIV-1 laboratory isolates</corefTheme> (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T15"/>
<cause idref="T10"/>
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was <clueKT>examined</clueKT> in detail <linkTheme>against</linkTheme> <corefTheme>HIV-1 laboratory isolates</corefTheme> (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event KT="Investigation" id="E11" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T17"/>
<cause idref="T10"/>
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was <clueKT>examined</clueKT> in detail <linkTheme>against</linkTheme> HIV-1 laboratory isolates (HTLV-IIIB, JRFL, and MN), <corefTheme>primary isolates</corefTheme> (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event KT="Investigation" id="E12" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T18"/>
<cause idref="T10"/>
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was <clueKT>examined</clueKT> in detail <linkTheme>against</linkTheme> HIV-1 laboratory isolates (HTLV-IIIB, JRFL, and MN), <corefTheme>primary isolates</corefTheme> (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event KT="Investigation" id="E13" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T20"/>
<cause idref="T10"/>
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was <clueKT>examined</clueKT> in detail <linkTheme>against</linkTheme> HIV-1 laboratory isolates (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and <corefTheme>simian immunodeficiency virus</corefTheme> (SIVmac251) in vitro.</clue>
</event>
<sentence id="S3"><term id="T21" lex="BMT" sem="Organic_compound_other">BMT</term> inhibited the replication of <term id="T22" lex="HIV-1" sem="Virus">HIV-1</term> in both laboratory and <term id="T23" lex="primary_isolates" sem="Virus">primary isolates</term> in vitro.</sentence>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T21"/>
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E15">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T21"/>
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T21"/>
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="T21"/>
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E18">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T21"/>
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event KT="Other" id="E19">
<type class="Viral_life_cycle"/>
<theme idref="T13"/>
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T13">HIV-1 in</corefTheme> both <corefTheme idref1="T13">laboratory</corefTheme> and primary <corefTheme idref1="T13">isolates</corefTheme> in vitro.</clue>
</event>
<event KT="Other" id="E20">
<type class="Viral_life_cycle"/>
<theme idref="T14"/>
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T14">HIV-1 in</corefTheme> both <corefTheme idref1="T14">laboratory</corefTheme> and primary <corefTheme idref1="T14">isolates</corefTheme> in vitro.</clue>
</event>
<event KT="Other" id="E21">
<type class="Viral_life_cycle"/>
<theme idref="T15"/>
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T15">HIV-1 in</corefTheme> both <corefTheme idref1="T15">laboratory</corefTheme> and primary <corefTheme idref1="T15">isolates</corefTheme> in vitro.</clue>
</event>
<event KT="Other" id="E22">
<type class="Viral_life_cycle"/>
<theme idref="T17"/>
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T17">HIV-1 in</corefTheme> both laboratory and <corefTheme idref1="T17">primary isolates</corefTheme> in vitro.</clue>
</event>
<event KT="Other" id="E23">
<type class="Viral_life_cycle"/>
<theme idref="T18"/>
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T18">HIV-1 in</corefTheme> both laboratory and <corefTheme idref1="T18">primary isolates</corefTheme> in vitro.</clue>
</event>
<sentence id="S4">In addition, <term id="T24" lex="BMT" sem="Organic_compound_other">BMT</term> exhibited <term id="T25" lex="antiviral_activity" sem="Other">antiviral activity</term> against <term id="T26" lex="SIVmac251" sem="Virus">SIVmac251</term>.</sentence>
<event KT="Analysis" id="E24">
<type class="Negative_regulation"/>
<theme idref="T26"/>
<cause idref="T24"/>
<clue>In addition, BMT <clueKT>exhibited</clueKT> <clueType>antiviral activity</clueType> <linkTheme>against</linkTheme> SIVmac251.</clue>
</event>
<sentence id="S5">Minimizing energy studies of <term id="T27" lex="BMT" sem="Organic_compound_other">BMT</term> structure reveal that a <term id="T28" lex="trans-disulfide" sem="Organic_compound_other">trans-disulfide</term> of <term id="T29" lex="thiamine" sem="Organic_compound_other">thiamine</term> (<term id="T30" lex="holo_drug" sem="Organic_compound_other">holo drug</term>) <term id="T31" lex="disulfide" sem="Organic_compound_other">disulfide</term> (<term id="T32" lex="TDS" sem="Organic_compound_other">TDS</term>, <term id="T33" lex="protodrug" sem="Organic_compound_other">protodrug</term>) is allosterically transited to the <term id="T34" lex="reactive_twisted_disulfide" sem="Organic_compound_other">reactive twisted disulfide</term> of <term id="T35" lex="BMT" sem="Organic_compound_other">BMT</term> (<term id="T36" lex="allo_drug" sem="Organic_compound_other">allo drug</term>) by <term id="T37" lex="o,o&apos;-bismyristoyl_esterification" sem="Other">o,o&apos;-bismyristoyl esterification</term> of <term id="T38" lex="TDS" sem="Organic_compound_other">TDS</term>.</sentence>
<sentence id="S6"><term id="T39" lex="BMT" sem="Organic_compound_other">BMT</term> inhibits <term id="T40" lex="nuclear_translocation" sem="Other">nuclear translocation</term> of both <term id="T41" lex="HIV-1_transactivator" sem="Protein_molecule"><term id="T42" lex="HIV-1" sem="Virus">HIV-1</term> transactivator</term> (<term id="T43" lex="TAT" sem="Protein_molecule">TAT</term>) and the <term id="T44" lex="cellular_transcriptional_nuclear_factor-KB" sem="Protein_molecule">cellular transcriptional nuclear factor-KB</term> (<term id="T45" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>), resulting in the suppression of <term id="T46" lex="HIV-1_replication" sem="Other"><term id="T47" lex="HIV-1" sem="Virus">HIV-1</term> replication</term>.</sentence>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<cause idref="T39"/>
<clue>BMT <clueType>inhibits</clueType> nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="T39"/>
<clue>BMT <clueType>inhibits</clueType> nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</clue>
</event>
<event KT="Other" id="E27">
<type class="Localization"/>
<theme idref="T42" idref1="T43"/>
<clue>BMT inhibits <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</clue>
</event>
<event KT="Other" id="E28">
<type class="Localization"/>
<theme idref="T42" idref1="T45"/>
<clue>BMT inhibits <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</clue>
</event>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="E25"/>
<clue>BMT inhibits nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), <clueType>resulting in the suppression</clueType> <linkTheme>of</linkTheme> HIV-1 replication.</clue>
</event>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="E26"/>
<clue>BMT inhibits nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), <clueType>resulting in the suppression</clueType> <linkTheme>of</linkTheme> HIV-1 replication.</clue>
</event>
<event KT="Other" id="E31">
<type class="Viral_life_cycle"/>
<theme idref="T47"/>
<clue>BMT inhibits nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 <clueType>replication</clueType>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
